急性缺血性卒中抗凝治疗研究进展
Research progress of anticoagulation therapy of acute ischemic stroke
摘要
急性缺血性卒中的抗凝治疗存在着很大的争议。本文综述了常用抗凝药物如肝素、低分子肝素的作用机制,并从循证医学角度对近年来发表的一些关于急性缺血性卒中抗凝治疗的大型临床试验进行了总结。
There are controversies in the anticoagulation therapy of acute ischemic stroke (AIS). In this paper, the mechanisms of some common anticoagulants such as heparin and low molecular weight heparin are reviewed and some related clinical trials reported recently are summarized according to evidence-based medicine.
出处
《中华神经医学杂志》
CAS
CSCD
2004年第6期473-476,共4页
Chinese Journal of Neuromedicine
参考文献10
-
1Kay R,Wong KS,Yu YL,et al.Low-molecular-weight heparin for the treatment of acute ischemic stroke[].The New England Journal of Medicine.1995
-
2Sandercock P.Full Heparin Anticoagulation Should Not Be Used in Acute Ischemic Stroke[].Stroke.2003
-
3Moonis M,Fisher M.Considering the Role of Heparin and Low-Molecular-Weight Heparins in Acute Ischemic Stroke[].Stroke.2002
-
4Berge E,Abdelnoor M,Nakstad PH,et al.Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study: HAEST Study Group Heparin in Acute Embolic Stroke Trial[].The Lancet.2000
-
5Bath PMW,Lindenstrom E,Boysen G,et al.Tinzaparin in acute ischemic stroke (TAIST): a randomized aspirin controlled trial[].The Lancet.2001
-
6Coull BM,Williams LS,Goldstein LB,et al.Anticoagulants and antiplatelet agents in acute ischemic stroke: Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a Division of the American Heart Association)[].Neurology.2002
-
7Saxena R,Lewis S,Berge E,et al.Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischaemic stroke and atrial fibrillation in the International Stroke Trial[].Stroke.2001
-
8Hommel M,for the FISS bis Investigators Group.Fraxiparine in Ischaemic Stroke Study: 7th European Stroke Conference; May 27-30, 1998; Edinburgh, UK[].Cerebrovascular Diseases.1998
-
9Hirsh J,Warkentin TE,Raschke R,et al.Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety[].Chest.1998
-
10Wardlaw JM.Overview of Cochrane thrombolysis meta-analysis[].Neurology.2001
-
1周腾飞,朱良付,李天晓.影响急性缺血性脑卒中血管内治疗预后的相关因素分析[J].介入放射学杂志,2017,26(2):99-104. 被引量：46
-
2童建明,殷俊先.老年期抑郁症的风险因素[J].国外医学（精神病学分册）,2001,28(1):11-13. 被引量：32
-
3刘鸣,郝子龙.从循证医学角度看多巴胺受体激动剂在帕金森病治疗中的作用[J].中国循证医学杂志,2010,10(3):232-234. 被引量：12
-
4杨卫红,林敬明.阿司匹林对缺血性卒中二级预防的大型临床试验[J].国外医学（脑血管疾病分册）,2002,10(4):271-274. 被引量：13
-
5杨卫红,林敬明.阿司匹林对卒中的一级预防大型临床研究[J].中风与神经疾病杂志,2003,20(3):283-285.
-
6曹菊（摘）.普拉克索可改善RLS的多个症状[J].国外药讯,2008(11):17-17.
-
7傅国萍,鲁国建,董芬.Rt-PA静脉溶栓治疗7例基底动脉尖脑梗死临床分析[J].心脑血管病防治,2015,15(1):74-75. 被引量：4
-
8乔金玲,李威.雌激素神经保护作用研究进展[J].国际脑血管病杂志,2008,16(5):365-369. 被引量：2
-
9范萍莉.精神分裂症患者康复干预的研究进展[J].中华现代护理杂志,2011,17(29):3575-3577. 被引量：11
-
10郭喜朝,张惠军,文殊,张靓.辛伐他汀治疗不稳定型心绞痛13例临床疗效观察[J].基层医学论坛（B版）,2006,10(5):461-461.
